Laboratory Reference Grade CompoundsInsulation Foam Protected • Dispatched Nationwide
Dispatched from Metro Manila · J&T Express•Instant GCash, Maya & Bank QR
Open Research Library · Free Scientific Reference
Research Library & Scientific Protocols
Peer-reviewed compound monographs, head-to-head peptide comparisons, product protocols, and precision diluent stoichiometry.
Research
100% Free Open Research Library & Comparison Engine
All articles, comparisons, and tools are freely accessible. Ordering compounds unlocks batch analytical monographs in the Customer Research Hub.
Peptide Head-to-Head Comparison
Compare mechanisms, investigated research benefits, side effects, half-life, and stacking compatibility.
Popular:
Specimen A
Specimen B
At-A-Glance Assessment
✨Synergistic (Can be stacked)BPC-157 vs. TB-500
Core Differentiation:
BPC-157 primarily targets Gastric Pentadecapeptide Laboratory Protocol & In-Vitro Angiogenesis Standard, whereas TB-500 focuses on Synthetic Thymosin Beta-4 Ac-LKKTETQ Actin-Sequestration Research Monograph.
Co-Administration Guidance:
The Wolverine Synergy: Angiogenic microvascular sprouting from BPC-157 provides nutrient perfusion, while TB-500 accelerates tenocyte and myoblast migration into the repaired zone.
Comparison Sections:
Investigated Research Benefits & Primary Endpoints
Documented laboratory findings, cellular actions, and targeted tissue responses:
BPC-157 Benefits6 Endpoints
✓
Accelerates Tendon & Ligament RegenerationStimulates tendon outgrowth, cell survival, and migration to repair connective tissues that normally have poor blood supply.
✓
Promotes Microvascular Blood Flow (Angiogenesis)Upregulates VEGF and eNOS to build fresh capillary networks, delivering oxygen and vital nutrients directly to injured cells.
✓
Gastrointestinal & Gut Lining ProtectionRebuilds damaged intestinal mucosa, strengthens tight junctions, and shields digestive tissue from inflammatory and chemical damage.
✓
Muscle & Soft Tissue RecoveryDecreases recovery times in animal soft-tissue strain models by promoting rapid collagen type I synthesis and myofiber remodeling.
✓
Counteracts NSAID-Induced DamageShields the stomach, liver, and intestines against lesions caused by prolonged use of pain relievers and anti-inflammatory compounds.
✓
Neuroprotective & Joint CytoprotectionCrosses systemic barriers to reduce inflammatory markers around peripheral nerves and articular cartilage surfaces.
TB-500 Benefits5 Endpoints
✓
Rapid Cell Migration & Tissue RemodelingMobilizes wound-healing cells across damaged areas to form smooth, healthy tissue rather than stiff scar tissue.
✓
Systemic Cardiovascular & Heart ProtectionPromotes survival of cardiac muscle cells and stimulates new capillary growth following ischemic or oxygen-deprived events.
✓
Reduces Chronic Inflammation & FibrosisDownregulates NF-kB transcription factors, dampening chronic tissue inflammation and preventing excess fibrotic scarring.
✓
Joint, Ligament & Muscle FlexibilityEnhances flexibility, reduces stiffness, and accelerates recovery in repetitive strain and athletic tissue models.
✓
Dermal & Wound Repair AccelerationSignificantly speeds up superficial and deep dermal wound closure, epithelial migration, and keratinocyte turnover.
Observed Side Effects, Tolerability & Risk Mitigation
Reported in-vitro and preclinical side effects, handling precautions, and dosage management:
BPC-157 Tolerability Profile3 Observations
⚠️
Mild Injection Site RednessTemporary redness, warmth, or mild itching at the subcutaneous injection point that typically resolves within 30 to 60 minutes.
⚠️
Occasional Mild Gastrointestinal UpsetRare, mild stomach cramping or loose stools when initiating research, often resolving as receptors adapt.
⚠️
Blood Pressure & Dizziness AdjustmentsTemporary mild dizziness or blood pressure dips immediately following administration due to nitric oxide (eNOS) vasodilation.
TB-500 Tolerability Profile4 Observations
⚠️
Transient Head Rush or FlushingA brief warm sensation, mild facial flushing, or lightheadedness may occur within 15 minutes of administration due to vascular shifts.
⚠️
Localized Surface ReactivityMinor subcutaneous localized sensitivity or temporary transient swelling at the application site that fades within an hour.
⚠️
Occasional FatigueTemporary lethargy or tiredness reported during early loading cycles as the body prioritizes tissue repair processes.
⚠️
Intermittent Dosing CadenceTypically researched on a twice-weekly loading schedule for 4 to 6 weeks, tapering to once weekly or bi-weekly maintenance.
Pharmacodynamics, Dosing & Storage Matrix
Side-by-side protocol parameters, research duration, reconstitution solvents, and storage stability:
| Evaluation Vector | BPC-157 | TB-500 |
|---|---|---|
| Primary Receptor Target | Gastric Pentadecapeptide Laboratory Protocol & In-Vitro Angiogenesis Standard | Synthetic Thymosin Beta-4 Ac-LKKTETQ Actin-Sequestration Research Monograph |
| Molecular Mass & Classification | 1419.55 g/mol (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)) | 4963.5 g/mol (Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ)) |
| In-Vitro Half-Life | ~4–6 Hours (Systemic peptide stability; localized extracellular retention ~24h) | ~24–36 Hours (Biological tissue effect extends up to 7–10 days via actin sequestration) |
| Reconstitution Standard | Bacteriostatic Water USP (0.9% Benzyl Alcohol) · 2 mL / 10 mg | Bacteriostatic Water USP (0.9% Benzyl Alcohol) · 2 mL / 10 mg |
| Standard Analytical Cadence | 1x Daily (or 250 mcg BID / Twice Daily in acute soft tissue trauma models) | 2x Weekly (e.g., Monday / Thursday SubQ) |
| Standard Research Dose | 250 mcg – 500 mcg daily | 2.5 mg twice weekly (5.0 mg/week total) |
| Research Cycle & Washout | Duration: 4 to 6 Weeks per analytical research blockWashout: 2 to 4 Weeks between experimental cycles | Duration: 6 to 8 WeeksWashout: 4 Weeks between experimental series |
| Delivery Route | Subcutaneous (SubQ) Protocol | Subcutaneous (SubQ) Protocol |
| Storage & Stability SOP | Lyophilized:-20°C in dry desiccator protected from moisture and light (24 months shelf-life) Reconstituted:2°C–8°C refrigerated; use within 28 days for optimal molecular stability | Lyophilized:-20°C in dark desiccator (24 months) Reconstituted:2°C–8°C refrigerated; use within 28 days |
| HPLC Purity & Quality Standard | ✓ ≥99.0% (HPLC-grade) | ✓ ≥99.0% (HPLC-grade) |
| U-100 Syringe Calibration | 5.0 units (0.05 mL)Standard U-100 Insulin Syringe (100 units = 1.0 mL) | 50.0 units (0.50 mL)Standard U-100 Insulin Syringe (100 units = 1.0 mL) |
Need reference materials for laboratory research?